DiRocco Derek
Insider CIK 1792061 · ACRV Director · ETNB Director · HOWL Director · ITOS Director · MLYS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 20,275 | — | $0 | 20,275 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 9,366 | — | $0 | 9,366 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-06-13 | 2025-06-17 | 20,275 | — | $0 | 20,275 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 20,275 | — | $0 | 20,275 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | A Award deriv | 2024-05-24 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,150 | — | $0 | 45,150 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | A Award deriv | 2023-06-21 | 2023-06-23 | 13,200 | — | $0 | 13,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2022-11-14 | 2022-11-16 | 35,235 | — | $0 | 35,235 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 11,600 | — | $0 | 11,600 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 16,608 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | A Award deriv | 2021-04-30 | 2021-05-04 | 23,200 | — | $0 | 23,200 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-10-21 | 16,608 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 16,608 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-06-22 | 2020-07-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-04-05 | 2020-04-07 | 7,000 | — | $0 | 7,000 | SEC↗ |